Implementation programme

Ebola’s Vaccine Trial Enters New Territory
Two vaccines specifically designed against Bundibugyo virus have been recommended for inclusion in the Democratic Republic of the Congo’s ongoing Ebola trial. Oxford’s ChAdOx1 candidate and Moderna’s mRNA-1469 could move the response beyond reliance on a vaccine developed for a different Ebola virus. Regulatory approval is still required. This is a scientific breakthrough in the…

Europe is building the infrastructure to decide which cardiovascular AI can be trusted

Skin Cancer AI Has Crossed a Line: It Is Discharging Patients on Its Own

Preparedness Finally Has Capital

Mpox Finally Gets A Stockpile

Cancer Survivorship Standards Are Still Mostly Paper

Ebola Is Killing People Before The System Finds Them.

The Cyclospora Test Was Wrong. Public Trust Cannot Be

New York Had Cooling-Tower Rules. Legionnaires’ Still Broke Through.

The Novo Nordisk Foundation is going global on cardiometabolic disease.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
